Discontinue use if paradoxical bronchospasm occurs. Not to be initiated during exacerbation or in patients w/ significantly worsening or acutely deteriorating asthma. Active or quiescent pulmonary TB, fungal & viral airway infections. Adrenal suppression, decreased bone mineral density, cataract, glaucoma; periods of stress, elective surgery; thyrotoxicosis, phaeochromocytoma, DM, untreated hypokalaemia, hypertrophic obstructive cardiomyopathy, idiopathic subvalvular aortic stenosis, severe HTN, aneurysm; severe CV disorders eg, ischaemic heart disease, tachyarrythmias or severe heart failure; QTc interval prolongation; visual disturbances. Pneumonia in patients w/ COPD. Risk of oropharyngeal candida infection. Monitor serum K & blood glucose levels. Transferring from previous systemic steroid therapy. Taper dose & avoid abrupt discontinuation. High-dose & prolonged use. Concomitant use w/ xanthine derivative, steroids, diuretics. Severe liver disease. Pregnancy & lactation. Not recommended for childn <6 yr. Growth retardation in childn & adolescents.
Sign Out
